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Tic suppression is the primary target of tic disorder treatment, but factors that influence
voluntary tic inhibition are not well understood. Several studies using the Tic Suppression
Task have demonstrated significant inter-individual variability in tic suppressibility but have
individually been underpowered to address correlates of tic suppression. The present
study explored patterns and clinical correlates of reward-enhanced tic suppression in
youth with tic disorders using a large, pooled dataset. Individual-level data from nine
studies using the Tic Suppression Task were pooled, yielding a sample of 99 youth
with tic disorders. Analyses examined patterns of tic suppressibility and the relationship
between tic suppressibility and demographic and clinical characteristics. A large majority
of youth demonstrated a high degree of tic suppression, but heterogeneous patterns
of tic suppressibility were also observed. Better tic suppressibility was related to older
age and more frequent tics but unrelated to other clinical variables, including presence
of psychiatric comorbidity, psychotropic medication status, tic and premonitory urge
severity, and self-rated tic suppressibility. The mechanisms underlying the observed
heterogeneity in reward-enhanced tic suppressibility warrant further investigation. The
Tic Suppression Task is a promising method for testing mechanistic hypotheses related
to tic suppression.
Keywords: tic, Tourette, suppression, child, adolescent

INTRODUCTION
Tic disorders (TDs) are childhood-onset conditions characterized by motor and/or vocal tics (1).
Unlike symptoms of many other movement disorders, tics associated with TDs are experienced
as “unvoluntary” (2) in that they can be inhibited via prefrontally-mediated cognitive control
mechanisms (3). The vast majority of patients describe tics as occurring in response to premonitory
urges, aversive somatosensory experiences that are temporarily alleviated by tic execution (4, 5). Tic
suppression is the primary target of behavioral, pharmacological, and neurostimulation treatments
(6, 7). Successful voluntary tic suppression underlies the effectiveness of empirically-supported
behavioral interventions for TDs, such as Comprehensive Behavioral Intervention for Tics [CBIT;
(6)], which teach specific skills for inhibiting tics in the presence of premonitory urges.
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video-rated tic suppression capacity and premonitory urge
severity (24, 25).
Somewhat more evidence from studies using the TST suggests
a possible relationship between tic suppression and attention
problems (e.g., those related to attention deficit hyperactivity
disorder; ADHD), although findings are mixed and derived from
small samples. Significant associations have been found between
decreased tic suppressibility and increased attention problems on
a parent-rated scale (26) and continuous performance task (19).
Interestingly, Greene et al. (13) reported significant correlations
between tic suppression and parent-rated attention problems but
in the opposite direction, such that those with more inattention
symptoms demonstrated greater tic suppression.
Although individual studies using the TST have advanced
our understanding of the factors that influence tic suppression,
clinically relevant questions about patterns and predictors
of suppression have been difficult to address within single,
small studies. The present study explored patterns and clinical
correlates of tic suppressibility in youth with TDs using a large,
pooled data set comprised of data from multiple laboratory
studies using the TST. First, we sought to describe the group-level
effect of suppression contingent reward on tic frequency and the
distribution of tic suppressibility across individuals. Second, we
aimed to evaluate candidate demographic and clinical correlates
of tic suppressibility. Based on prior research, we hypothesized
that better tic suppression would be positively associated with
older age and premonitory urge intensity, while poorer tic
suppression would be associated with an ADHD diagnosis.

Given the central importance of voluntary tic inhibition to
nonpharmacological tic management, researchers have studied
various questions related to tic suppression using the Tic
Suppression Task (TST) developed by Woods and Himle [(8);
also see (5, 9–15)]. In this paradigm, a participant is seated in
front of a computer or token dispenser and told it is a “tic
detector.” In reality, an experimenter unobtrusively observes
the child (e.g., using a one-way mirror), and tic frequency
is measured via direct observation coding. This deception is
employed to reduce reactivity effects, as observation can have
significant and non-uniform effects on tic expression (16).
Standard TST conditions include baseline (BL; instruction to
let tics occur freely) and reinforced suppression (SUP; instruction
to suppress tics plus reward delivered by “tic detector” after every
10 s tic-free interval). Additional conditions have been added
to this basic paradigm to test experiment-specific hypotheses.
Typically, participants are exposed to brief segments of each
condition (e.g., 5–10 min) in alternating or random order,
with multiple iterations of each condition. The key dependent
variable is tic frequency, calculated as a mean rate of tics per
minute for each condition. This design allows for within-subject
analyses of tic rate by condition and group-level analyses to
describe aggregate patterns across conditions. The first study
using the TST (n = 4; 8) demonstrated a substantial decrease
in tic frequency from BL to SUP (76.3% reduction), which far
exceeded the ∼10% decrease from BL to “verbal instruction”
condition (instructions to suppress without supporting reward
contingency). Subsequent research has repeatedly and reliably
replicated this effect of reward-enhanced suppression on tic
frequency [e.g., (17–19)].
Despite robust findings of reward-enhanced suppression at
the group level, significant inter-individual variability in degree of
tic suppressibility has been noted. Reasons for this heterogeneity
are unknown. Individual studies using the TST have been
underpowered to assess correlates of suppression because of
reliance on small samples (Ns = 4–15), reflecting feasibility
limitations inherent in studying a low-prevalence disorder.
Researchers have theorized, or indirectly demonstrated, that tic
suppressibility heterogeneity may be related to demographic and
clinical factors, such as age, premonitory urge severity, and cooccurring psychopathology (19, 20).
Age and premonitory urge severity have been theorized
to impact tic suppression, but supporting evidence is limited.
Some have suggested that adults and older children/adolescents
may be better able to suppress tics due to increased capacity
to sustain attention to effortful tasks (3, 8). Consistent with
this, Banaschewski et al. (21) found that older youth were
more likely to self-report an ability to suppress tics (age 15–
19 years > 11–14 years > 8–10 years). However, the age-tic
suppression relationship has yet to be tested using objective tic
frequency data. Premonitory urges may facilitate tic suppression
by serving as a cue to engage in suppression (4). Experimental
research on the urge-tic temporal relationship has confirmed
that urge intensity increases prior to tics and that tics are more
likely to occur when urges are higher (22, 23). Whether urges
are a prerequisite for successful suppression is unclear, with
two studies in adults demonstrating no association between
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METHODS
Study Detection
A literature search in databases PubMed and PsycINFO identified
research studies utilizing the TST (8) that included conditions
of BL and SUP. Fourteen studies were identified and authors
were contacted to request individual level, de-identified data for
published studies or other protocols their lab had disseminated
via peer-reviewed abstracts/conference presentations. All authors
responded to our inquiry. Data were available for 9 studies
(5, 9, 10, 12, 13, 15, 19, 27, 28). Individual-level datasets were no
longer available for older studies (8, 14, 18, 20, 26). A summary
of included studies is presented in Table 1. The current study was
determined by the Lifespan-Rhode Island Hospital Institutional
Review Board (IRB) to not qualify as human subjects research
due to the use of de-identified data only. Source studies were all
approved by local IRBs.

Participants
To be included in current analyses, individual participants
must have met DSM-IV-TR or DSM-5 criteria for a tic
disorder (Tourette Disorder, Chronic/Persistent Tic Disorder,
or Transient/Provisional Tic Disorder) and had available a Yale
Global Tic Severity Scale [YGTSS; (29)] total severity score and
tic frequency scores (tics per minute) for conditions of BL and
SUP. A total of 99 youth met inclusion criteria. Note that these
are all different individuals, as participation in a TST study
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N

13

9

10

4

12

15

Study

Woods et al.
(19)

Conelea and
Woods (10)

Conelea et al.
(12)
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Capriotti et al.
(27)

Specht et al.
(15)

3

Capriotti et al.
(5)

• Age 8–17 years
• Diagnosis of TS or CTD
• Intellectual functioning in
low-average range or above
• YGTSS severity score ≥13 and
<30 for TS or ≥9 and <20 for CTD
• 1 visible tic per min

• Age 10–17 years
• Diagnosis of TS or CTD
• Intellectual functioning in
low-average range or above
• YGTSS severity score ≥14 for TS
or ≥10 for CTD
• PUTS score ≥12
• 1 visible tic per min

• Diagnosis of TS or CTD
• Intellectual functioning in
low-average range or above
• YGTSS severity score ≥14
• 1 visible tic per min

• Age 9–17 years
• Diagnosis of TS or CTD
• Intellectual functioning in
low-average range or above
• YGTSS severity score ≥14 for TS
or ≥10 for CTD
• 1 visible tic per min

• Age 10–17 years
• Diagnosis of TS or CTD
• Intellectual functioning in
low-average range or above
• YGTSS severity score ≥14 for TS
or ≥10 for CTD
• 1 visible tic per min

• Age 10–17 years
• Diagnosis of TS
• Intellectual functioning in
low-average range or above

Inclusion criteria

• History of ≥3 sessions of
suppression-based behavior
therapy for tics
• Current or past psychotic,
substance use, or bipolar disorder
• Significant suicidal ideation and/or
attempts in past 3 months
• Medication changes in past 4
weeks

• History of ≥3 weeks of
suppression-based behavior
therapy for tics
• Comorbid CD or ODD with severity
rating ≥4 on ADIS-IV
• Antipsychotic, anti-hypertensive,
benzodiazepine, or selective
serotonin reuptake inhibitor
medications

• History of behavior therapy for tics
• Comorbid ADHD, or CD, ODD with
severity rating ≥5 (≥6 for ADHD) on
ADIS-IV

• Comorbid ADHD, or CD, ODD with
severity rating >6 on ADIS-IV
• History of ≥3 sessions of
suppression-based behavior
therapy for tics

• Comorbid ADHD, or CD, ODD with
severity rating >6 on ADIS-IV
• History of ≥3 sessions of
suppression-based behavior
therapy for tics

• History of suppression-based
behavior therapy for tics
• Medication changes in past 4
weeks

Exclusion criteria

TABLE 1 | Key design features of the studies included in pooled dataset.

MINI-Kid

ADIS-IV

ADIS-IV

ADIS-IV

ADIS-IV

ADIS-IV

Diagnostic
interview

• 10 min initial BL
• Subsequent BL were
5 min
• Repeated 4 times in fixed
order
• Urge ratings every 30 s

• 10 min
• BL was first condition
• Repeated 2 more times in
fixed order
• Urge rating every 10 s

• 5 min
• BL was first condition
• Repeated 4 more times in
fixed order

• 10 min initial BL
• 5 min thereafter
• Repeated 2 times in
random order

• 6 min
• Repeated 3 times in
random order

• 10 min
• At start of session

BL description

• 5 min
• Repeated 4 times in fixed
order
• Point for every 10 s
tic-free interval
• Urge ratings every 30 s

• 40 min
• Repeated twice in fixed
order
• Token for every 15 s
tic-free interval
• Urge rating every 10 s

• 5 min
• Repeated 4 times in fixed
order
• Point for every 5 s tic-free
interval

• 5 min
• Repeated 2 times in
random order
• Token for every 10 s
tic-free interval

• 6 min
• Repeated 3 times in
random order
• Token for every 10 s
tic-free interval

• Three SUP durations (5,
25, and 40 min)
• Token for every 10 s
tic-free interval

SUP description

(Continued)

• SUP wit option for 10 s
“free to tic” time-out
periods

n/a

• Response cost involving
loss of points for each tic

• Stress induction SUP
paired with stress
induction

• SUP paired with
attention-demanding task

• 5 min rebound evaluation
phase after every SUP

Additional conditions

Conelea et al.
Tic Suppressibility
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• Age 9–17 years
• Diagnosis of TS or CTD
• Intellectual functioning in
low-average range or above
• YGTSS severity score ≥14 and
<35 for TS or ≥10 and <20 for
CTD
• 1 visible tic per min

5

21

12

Capriotti et al.
(9)

Greene et al.
(13)

Conelea et al.
(28)

4

MINI-Kid

• History of ≥3 sessions of
suppression-based behavior
therapy for tics
• Psychosis, pervasive
developmental, or autism spectrum
disorder
• Mental retardation or cognitive
disability
• Current suicidal intent
• Medication changes during study
period
• 5 min
• Repeated 3 times in
random order

• 5 min
• BL was first condition
• Repeated once more in
random order

• 6 min
• BL was first condition
• Repeated 2 more times in
random order

MINI-Kid

K-SADS

BL description

Diagnostic
interview

• Neurological disorder other than
tics or migrane, known structural
brain disease, mental retardation,
autism, psychosis, mania, current
major depression, severe systemic
illness

History of behavior therapy for tics
Significant suicidal ideation
Neuroleptic medication
Psychotic, substance use, or
autism spectrum disorder
• Medication changes in past 6
weeks
• If on stimulant, adherence for past
3 days and no dose within 10 h of
task

•
•
•
•

Exclusion criteria

• Response cost involving
loss of points for each tic

• 5 min
• Repeated 3 times in
random order
• Point for every 10 s
tic-free interval

to

• Verbal instructions
suppress
• Non-contingent
reinforcement

• SUP with increasing point
value for each
consecutive 10 s tic-free
interval

Additional conditions

• 5 min
• First time in fixed order
• Repeated once more in
random order
• Token for every 10 s
tic-free interval

• 6 min
• Repeated 4 times in
random order
• Point for every 10 s
tic-free interval

SUP description

ADHD, attention deficit hyperactivity disorder; ADIS-IV, Anxiety Disorders Interview Schedule-Fourth Edition; BL, baseline; CTD, chronic tic disorder; CD, conduct disorder; K-SADS, Kiddie-Schedule for Affective Disorders and
Schizophrenia; MINI-Kid, Mini Neuropsychiatric Interview for Children and Adolescents; ODD, oppositional defiant disorder; PUTS, Premonitory Urge for Tics Scale; SUP, suppression plus contingent reward; TD, tic disorder; TTD,
transient tic disorder; TS, Tourette Syndrome; YGTSS, Yale Global Tic Severity Scale.

• Age 10–17 years
• Diagnosis of TS or CTD
• YGTSS severity score ≥14 for TS
or ≥10 for CTD
• 1 visible tic per min
• English fluency

• Diagnosis of TTD
• English proficiency

Inclusion criteria

N

Study

TABLE 1 | Continued
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medication status). Nonparametric tests were used when data
did not meet t-test assumptions. A two-tailed Wilcoxon signedrank test was used to compare tic frequencies in BL and SUP.
The Mann-Whitney test was used to examine tic suppressibility
within specific medication classes given unequal sample size
distribution. Pearson’s correlations were used to examine the
relationship between tic suppressibility and continuous variables
(age, total YGTSS and PUTS scores, baseline tic frequency).

involving the deception element precludes participation in future
TST-based research (all included studies involved deception).

Measures
Measures were selected based upon common availability across
studies. Demographic variables included age, gender, and
medication status. Medication status was available for n = 97.
Due to study variability in medication tracking methods,
medication status was coded as presence vs. absence of (1) any
psychotropic medication, (2) antipsychotic, (3) stimulant, (4) α2
adrenergic agonist, or (5) serotonin reuptake inhibitor (SRI).
Psychiatric diagnostic status was determined using wellvalidated, structured clinical interviews (see Table 1). Psychiatric
comorbidity data were available for 87 youth [excluding (19)]
and grouped into the following major diagnostic categories:
(1) anxiety disorders (generalized anxiety, separation anxiety,
social anxiety, specific phobia, panic, and post-traumatic stress
disorders), (2) obsessive-compulsive disorder (OCD), and (3)
ADHD (any subtype). Mood disorders (major depressive and
bipolar disorders, dysthymia) were not analyzed as only n = 1 had
a mood diagnosis. Note that some studies had exclusion criteria
related to specific psychiatric diagnoses (see Table 1).
Tic severity was measured using the YGTSS, a clinician-rated
assessment of tic severity over the past week that produces an
overall tic severity score ranging from 0 to 50, such that higher
scores indicate greater severity (29). Premonitory urge intensity
was measured using the Premonitory Urge for Tics Scale [PUTS;
(30)], a self-report measure. Items 1–9 are summed to yield a total
score ranging from 9 to 26, such that higher scores indicate more
intense urge experiences. PUTS total scores were available for 88
youth. PUTS Item 10 does not contribute to the total score but
was included in some studies [n = 63; (10, 12, 15, 19, 28)]. Item
10 measures perceived tic suppressibility (“I am able to stop my
tics, even if only for a short period of time”) and was examined in
a separate analysis from the PUTS total scores.
Tic frequency scores represent the mean number of tics per
minute for all within-subject replications of a given condition (BL
or SUP), such that each participant had one mean tic frequency
score for each condition. To assess the degree to which youth
were able to suppress tics during SUP, we calculated a percent
change variable that we refer to here as “tic suppressibility”
[(BL tic frequency-SUP tic frequency)/BL tic frequency∗ 100].
Positive values indicate tic reduction during SUP (i.e., better
suppression), near-zero values indicate little to no difference
between conditions (i.e., poor suppression), and negative values
indicate tic increase during SUP (i.e., tic worsening during
suppression conditions). Of note, this score is similar to but
distinct from a change score formula used previously to index
tic suppression [i.e., tic “inhibition potency”; (24, 25, 31)], as the
dependent variable in those studies was the total score on the
Modified Rush Video Rating Scale (32).

RESULTS
Participant Characteristics
Participants had a mean age of 11.2 years (SD = 3.0, range = 5.0–
17.7). Gender distribution reflected the known preponderance of
tics in males (male: n = 78, female: n = 21). Forty-two youth
(42.4%) had a co-occurring psychiatric diagnosis. Thirty-three
had ADHD, 28 had an anxiety disorder, 15 had OCD, and 1 had a
mood disorder; 21 had more than one comorbid diagnosis. About
one-third were taking a psychotropic medication (n = 29, 29.3%);
17 were taking more than one medication. In terms of specific
medication classes, 12 (12.1%) were taking an α2 adrenergic
agonist, 10 (10.1%) an SRI, 9 (9.1%) a stimulant, and 8 (8.1%)
an antipsychotic.
Tic severity on the YGTSS fell in the moderate range
(m = 22.3, SD = 7.7, range = 7–39). The mean PUTS total
score reflected moderate urge intensity (m = 18.1, SD = 6.2,
range = 9–31).

Tic Suppressibility
BL mean tic frequency was 7.6 tics per min (SD = 5.9,
median = 6.2) and SUP was 2.6 tics per min (SD = 2.9,
median = 0.8). Data were not normally distributed (BL:
zskewness = 1.5, zkurtosis = 2.96; SUP: zskewness = 2.1, zkurtosis = 4.5;
all p < 0.001). Tic frequency was significantly lower during SUP
than BL, T = 20.7, z = −7.9, p < 0.001, and the observed effect
size was large, r = −0.56.
Median tic suppressibility was 71.1% (SD = 38.3), and 89.8%
of participants (n = 89) had scores above zero, indicating lower
tic rate during SUP than BL. Wide variability was observed
(−61.5% through 98.8%; see Figure 1). About 70% (n = 71)
of participants had at least a 50% decrease in tic frequency.
Notably, 20.2% (n = 20) showed near complete suppression
during SUP (90% or greater reduction), 10.1% (n = 10) showed
no suppression (tic suppressibility between −25 and 25%), and
7.1% (n = 7) showed tic worsening when trying to suppress (26%
or greater increase).

Relationship of Tic Suppressibility to
Demographic and Clinical Characteristics
Age was positively correlated with tic suppressibility, r = 0.34,
p = 0.001, such that older children demonstrated a greater degree
of tic suppression (Figure 2). There was no gender difference in
tic suppressibility, t = −1.19, p = 0.23. Tic suppressibility did
not differ based on the presence of any psychiatric comorbidity
(t = −0.28, p = 0.77) nor specifically in terms of ADHD (t = 0.95,

Data Analysis Plan
All measures were examined descriptively. The relationship
between tic suppressibility and demographic/clinical
characteristics was assessed using independent samples ttests for dichotomous variables (gender, diagnostic status,

Frontiers in Psychiatry | www.frontiersin.org
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FIGURE 1 | Tic suppressibility across participants.

FIGURE 2 | Tic suppressibility as a function of age. Hashed line represents a least-squares regression line fitted to the data.

DISCUSSION

p = 0.34), anxiety disorder (t = −0.02, p = 0.98), or OCD status
(t = −0.43, p = 0.67).
There was no difference in tic suppressibility for those taking
vs. not taking a psychotropic medication, t = −0.73, p = 0.46.
No differences in tic suppressibility were found for specific
medication classes: antipsychotic (n = 8), U = 329.0, p = 0.72;
stimulant (n = 9), U = 277.0, p = 0.13; α2 adrenergic agonist
(n = 12), U = 431.0, p = 0.38; SRI (n = 10), U = 320.0,
p = 0.17.
Baseline tic frequencies and tic suppressibility were
significantly correlated (r = 0.26, p = 0.007), such that
those with more frequent tics at baseline showed greater tic
suppressibility. Correlations of tic suppressibility with YGTSSmeasured tic severity (r = 0.18, p = 0.07) and with PUTS-rated
premonitory urge severity (r = 0.15, p = 0.15) were in the same
direction but not significant. Self-rated ability to suppress tics,
as measured by item 10 on the PUTS, was not significantly
correlated with our objective tic suppressibility metric (r = 0.18,
p = 0.15).

Frontiers in Psychiatry | www.frontiersin.org

We evaluated reinforced tic suppression and its correlates using
data from 99 youth with TDs pooled across nine studies. Results
showed that a large majority of youth achieved robust tic
suppression when attempting to suppress tics in the presence
of a supporting reward contingency, but significant interindividual heterogeneity in tic suppressibility was also observed.
Results regarding correlates of tic suppression were only partially
consistent with a priori predictions: tic suppressibility was
positively related to child age (older children tended to suppress
more effectively) but not significantly related to premonitory urge
severity or ADHD diagnosis.
That robust tic suppression was observed in a majority of
participants may be seen as unsurprising, given positive results
of prior studies whose data contributed to this study. However,
the nature of interindividual variability in tic suppressibility has
been difficult to characterize in previous small studies. Though a
large majority demonstrated a high degree of tic suppression (i.e.,
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the Greene et al. (13) study indicated (included in this pooled
dataset), even younger children demonstrate some tic inhibition
capacity. Future research exploring the relationship between the
TST and CBIT response may help refine our understanding of
the “optimal” or minimal age to implement CBIT. It is also
important to acknowledge that tic suppressibility is unlikely to
be the sole moderator of behavior therapy outcome; for example,
other developmentally sensitive patient characteristics such as tic
awareness and motivation likely also contribute to response.
The presence of comorbid psychiatric disorders was not
associated with differential tic suppressibility. Although
comorbidity has been shown to adversely impact psychosocial
functioning in those with TDs [e.g., (42)], the literature has been
inconclusive in terms of comorbidity effects specifically on tic
suppressibility. Interestingly, although anxiety disorders have
been found to predict poorer response to CBIT (41), we found
no evidence of impaired tic suppression in youth with comorbid
anxiety.
ADHD has been the disorder most frequently hypothesized
to be detrimental to tic suppression, based on the rationale
that tic suppression involves attentional and inhibitory control
mechanisms that are impaired in those with ADHD. Our results
are consistent with previous studies showing that youth with
ADHD can achieve robust tic suppression (14) and benefit
comparably from CBIT (41). As ADHD is known to have
a heterogeneous neurocognitive profile (43), tic suppression
may be related to neurocognitive and/or learning processes
that are implicated in ADHD, rather than related directly to
the ADHD clinical phenotype. One interesting consideration is
whether suppression contingent reinforcement might mitigate
the impact of ADHD on tic suppression, which would be
consistent with research showing enhanced sensitivity to reward
in children with ADHD (44). This possibility could be tested
by comparing tic suppressibility with and without a supporting
reward contingency in children both with and without ADHD.
Empirical evaluation of this possibility might guide treatment
refinement, as it could indicate whether reinforcement to
enhance suppression bolsters treatment response in youth with
tics and ADHD.
We also found no difference in tic suppressibility related
to psychotropic medication status. This parallels previous
research showing that dexmethylphenidate does not impair tic
suppression during the TST in youth with tics and ADHD (14).
We did not find evidence of impaired tic suppression among
youth taking antipsychotic medication, which is incongruent
with findings showing blunted response to CBIT among
individuals on these medications (41). However, null findings
in terms of medication class effects should be interpreted with
caution given the small numbers of children taking specific
medications. It is also notable that medicated youth in this sample
still met study entry criteria involving a moderate degree of tic
severity, meaning that they could be undertreated or medication
non-/sub-optimal responders. Future research could use the TST
to more rigorously test whether specific medications impact
tic suppression, either in an experimental fashion (14) or as a
pre-post assessment when medication withdrawal is not feasible.
We did not find a significant relationship between tic
suppressibility and tic severity, as measured by the YGTSS.

70% of youth had at least a 50% decrease in tic frequency), we
also observed sizable portions of the sample to show particularly
striking patterns of suppression, including 20% who had near
complete suppression, 10% who seemed unable to suppress, and
7% whose tics worsened during SUP.
It is critical to note that results describe tic suppressibility in
an austere lab setting with an immediate reward contingency
supporting suppression. Thus, the ability of these participants
to suppress tics under naturalistic conditions is unknown.
Behavioral interventions (e.g., CBIT) focus on tic suppression
practice in everyday life; thus, the present findings do not
suggest that most youth with tics already have the same
tic suppressing repertoire which behavior therapies aspire to
develop. Instead, we suggest that most youth naive to behavior
therapy can indeed voluntarily suppress tics under certain,
“ideal” conditions. Therapy focuses on enhancing suppression
abilities and generalizing them to more naturalistic contexts,
so that skills may be utilized concurrently with engagement in
normal activities and in the absence of contrived reinforcement
contingencies. Whether tic suppressibility during the TST in
treatment naive youth predicts response to CBIT remains an
empirical question that, if explored, could help determine the
potential application of the TST as an assessment tool. From an
experimental perspective, the notion that tic suppression can be
experimentally induced for most children confirms the utility
of this paradigm for systematic tests of how extraneous factors
perturb or enhance tic suppression, such as contextual events or
medication inductions.
The finding that tic suppressibility improves with age is
a novel finding consistent with a neurodevelopmental view
of TDs. The ability to suppress interfering actions develops
throughout childhood and adolescence and is driven by
functional and structural maturation of the prefrontal-striatal
network (33). Although TDs are associated with atypical
function in control-related regions (34, 35), based on maturation
alone we would still expect older youth to have greater topdown control of tics compared to their younger counterparts.
The notion that older people with tics develop altered or
compensatory neurofunctional organization of motor control
networks as a result of tic suppression experience has also
been proposed to explain findings that those with TDs tend
to show normative or enhanced behavioral performance on
motor control tasks (36–38). Given that suppression occurred
in the context of reward, it is also possible that the age finding
reflects the particular heightened responsiveness to reward
in adolescence vs. both childhood and adulthood, which has
been attributed to imbalanced maturation of limbic regions
relative to cortical control regions (39). Alternatively, age-related
differences may simply be due to the fact that older children have
experienced longer illness duration, lending greater opportunity
to naturally develop and practice short-term tic suppression
strategies. Testing youth longitudinally with the TST may inform
developmental models of tic suppression.
The clinical relevance of the age finding remains unclear
given that the relationship between tic suppression on the TST
and behavior therapy response is untested. The seminal CBIT
trial demonstrated efficacy in youth ages 9 years and above
(40), and age did not moderate outcome (41). However, as
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ratings of tic suppressibility may also be susceptible to self-report
biases, further highlighting the clinical importance of including
objective measurements in tic assessment.
Our findings have implications for future research.
Mechanistic work is needed to identify the reasons for
heterogeneous patterns of tic suppression across individuals.
Based on our current findings and the prior literature, it
now seems clear that variables capturing broad clinical
characteristics are not useful as predictors or moderators of tic
suppressibility and are therefore unlikely to shed light into the
mechanisms underlying suppression or to have prognostic utility.
Candidate mechanisms should be explored using fine-grained,
transdiagnostic variables that provide better insights into
brain-context-behavior interactions that drive tic suppressibility.
The TST continues to hold strong promise as a method
for probing mechanisms underlying tic suppression, particularly
because it is a well-established laboratory task that can be paired
with examination of other units of analysis (e.g., neurocircuitry).
As researchers continue to use the TST, attention should also
be paid to understanding how the design and implementation
of the task itself may influence findings. The extent to which
results are comparable to findings from studies using other direct
observation tic suppression paradigms is unclear. For example,
other paradigms have focused on assessing tic suppression
without a supporting reinforcement contingency and measured
tics using multidimensional symptom ratings (25, 31). Given that
tics are known to be highly reactive to contextual factors (11),
it is possible that seemingly minor methodological differences
between paradigms impact findings, such as the wording of
instructions to suppress. Our understanding of task specific
effects might be improved with direct comparisons between
different suppression paradigms and dissemination of paradigm
methods in greater detail.
Limitations of the current study include those inherent to
combining a dataset across studies, such as statistical weaknesses
associated with secondary analyses, method variance across
projects, possible uncontrolled or unmeasured site effects, and
access to only a limited range of variables that were common
across studies. We did not have access to information about
medication indications, and only a small number of participants
were taking medications in each examined medication class.
Some studies had inclusion criteria related to scores of measures
examined in correlational analyses [i.e., all but the (13)
study had criteria reflecting minimum YGTSS scores; (15)
required a particular PUTS score]. Finally, continuous measures
of comorbidity were not available. Although comorbidity
rates parallel those reported for clinical trials with similar
inclusion/exclusion criteria (50), rates are lower than those
expected in the general TD population.
In conclusion, our results indicate that a large majority
of youth with tic disorders are able to achieve robust tic
suppression in a laboratory tic suppression paradigm. Better
tic suppressibility was related to older age and more frequent
tics but unrelated to other clinical variables. The mechanisms
underlying the observed heterogeneity in tic suppressibility
warrant further investigation, as enhancement of tic suppression
is a key treatment target. The TST holds promise as a method

This finding may reflect the notion that tic generation and
tic suppression are separate processes subserved by different
loops of cortico-striatal-thalamo-cortical (CSTC) circuits (45).
Findings may also reflect measurement variance. The YGTSS
total score is a global rating of multiple dimensions of tic
symptomatology over the previous week. Of these dimensions,
tic frequency has been the sole dependent variable in TST studies.
How suppression efforts impact other symptom dimensions,
such as tic intensity or complexity, remains unknown and should
be tested in future research. It is notable that a significant
correlation was found between tic frequency at baseline and tic
suppressibility, such that youth with more frequent tics during
BL showed a greater degree of suppression. While it is possible
that this finding is a measurement artifact (i.e., more frequent
tics yield more opportunity to have a larger change score),
it may also be the case that more frequent tics afford more
“real life” practice in suppression, which could enhance skills
related to suppression (e.g., greater awareness of tic sensations,
naturally formed competing motor behaviors) and development
of compensatory neurocircuits.
Tic suppressibility was not significantly correlated with
PUTS-rated premonitory urge severity. Behavioral models
have conceptualized premonitory urges as a facilitator of tic
suppression, as they provide salient cues to initiate tic inhibition
(6). In recent years, findings, including those in the current study,
call this idea into question (13, 23, 24, 46), instead suggesting
that the urge-tic relationship is heterogeneous across individuals
and more nuanced than once thought [(5, 17, 22)]. For example,
in the CBIT trials (41), individuals with higher PUTS scores
demonstrated blunted treatment response, raising the possibility
that higher urges are associated with a more treatment-refractory
form of TD. Neuroimaging studies indicate that distinct neural
circuits subserve tic and urge generation (45, 47), suggesting
that the two processes are at the least dissociable, even if not
necessarily dissociated under all conditions. Our reliance on the
PUTS as a measure of urge severity may also have influenced
results. Recent psychometric testing of the PUTS suggests that
the PUTS does not show strong associations with real-time urge
intensity monitoring and may measure more than one dimension
of the urge experience [e.g., both quality and intensity of urge
sensations; (48)]. Re-examination of the urge-tic suppressibility
relationship will be important if the PUTS undergoes further
refinement to improve its sensitivity to measure multiple urge
dimensions.
Interestingly, our objective measure of tic suppressibility
was not significantly associated with self-rated tic suppression
ability, as measured by item 10 of the PUTS. This finding is
consistent with other research demonstrating the unreliability
of subjective reports of tic severity (25). For example, in a
study by Barnea et al. (49), youth with tics subjectively rated tic
experiences across several daily-life situations, and tic frequencies
were then objectively measured for these situations (e.g.,
watching television, doing homework, being alone). Associations
between subjective and objective measures of tic expression
were moderate to low, challenging the long-standing clinical
assumption that the affected individual is able to accurately
report on his/her own tics. Our study suggests that subjective
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